Gland Pharma Ltd (GLAND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003443, "name": "Gland Pharma", "stock_name": "Gland Pharma", "full_name": "Gland Pharma Ltd", "name_url": "stocks-analysis/gland-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,596.00", "chg": -31.75, "chgp": "-1.95%", "dir": -1, "prev_price": "1,627.75", "mcapval": "26,295.13 Cr", "mcap": "Small Cap", "scripcode": 543245, "symbol": "GLAND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE068V01023", "curr_date": "Mar 16", "curr_time": "", "bse_nse_vol": "34.34 k", "exc_status": "Active", "traded_date": "Mar 16, 2026", "traded_date_str": "2026 03 16", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Gland Pharma Downgraded to Sell Amid Technical Weakness and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3892868", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_mojoScore_3892868.png", "date": "2026-03-16 08:15:04", "description": "Gland Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 March 2026. The downgrade reflects a combination of deteriorating technical indicators, expensive valuation metrics, subdued long-term financial growth, and mixed quality assessments, signalling caution for investors despite recent positive quarterly results." }, { "title": "Gland Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-faces-bearish-momentum-amid-technical-downgrade-3892789", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3892789.png", "date": "2026-03-16 08:03:02", "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from Hold to Sell by MarketsMOJO, coupled with a 1.96% decline in price, reflects growing investor caution amid mixed technical signals and underwhelming short-term returns compared to the broader Sensex." }, { "title": "Gland Pharma Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-3888303", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_mojoScore_3888303.png", "date": "2026-03-13 10:10:43", "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Gland Pharma Declines 8.45%: Four Key Factors Shaping This Week’s Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-declines-845-four-key-factors-shaping-this-weeks-performance-3878139", "imagepath": "", "date": "2026-03-07 12:04:54", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Significant gap down opening amid market concerns</p>\n <p><strong>4 Mar:</strong> Technical momentum shifts with mixed indicator signals</p>\n <p><strong>4 Mar:</strong> Valuation shift signals improved price attractiveness</p>\n <p><strong>5 Mar:</strong> Technical momentum turns mildly bearish amid volatility</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,823.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3872721", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3872721.png", "date": "2026-03-05 08:04:50", "description": "Gland Pharma Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from sideways movement to a mildly bearish trend. Despite a recent downgrade from Sell to Hold by MarketsMOJO on 18 Feb 2026, the stock’s technical landscape reveals both bullish and bearish signals, warranting a nuanced analysis for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3868349", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_technicaldot_3868349.png", "date": "2026-03-04 08:06:55", "description": "Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more sideways trend as of early March 2026. Despite a recent downgrade in daily moving averages and a slight dip in share price, the company’s weekly and monthly technical indicators present a complex picture, reflecting mixed signals for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Gland Pharma Ltd Valuation Shift Signals Price Attractiveness Amid Sector Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-valuation-shift-signals-price-attractiveness-amid-sector-dynamics-3868094", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_valuationdot_3868094.png", "date": "2026-03-04 08:01:32", "description": "Gland Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle improvement in price attractiveness. Despite a recent day decline of 1.79%, the pharmaceutical company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more balanced valuation relative to its historical levels and peer group, signalling a potential recalibration for investors assessing the stock’s medium-term prospects." }, { "title": "Gland Pharma Ltd Opens with Significant Gap Down Amid Market Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-ltd-opens-with-significant-gap-down-amid-market-concerns-3865252", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_gapdown_3865252.png", "date": "2026-03-02 13:34:22", "description": "Gland Pharma Ltd commenced trading today with a pronounced gap down, opening at a price 6.74% lower than its previous close, reflecting heightened market concerns and a continuation of recent downward momentum in the pharmaceutical sector." }, { "title": "Gland Pharma Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-ltd-is-rated-hold-by-marketsmojo-3864337", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlandPharmaLtd_mojoScore_3864337.png", "date": "2026-03-02 10:10:03", "description": "Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." } ], "total": 358, "sid": "1003443", "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "13-Mar-2026", "details": "Schedule of Investor Meet Intimation", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "11-Mar-2026", "details": "Schedule of Investor Meet", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "09-Mar-2026", "details": "Schedule of Investor Meet Intimations", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Mar: Significant gap down opening amid market concerns

4 Mar: Technical momentum shifts with mixed indicator signals

4 Mar: Valuation shift signals improved price attractiveness

5 Mar: Technical momentum turns mildly bearish amid volatility

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-05 08:04:50

Gland Pharma Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from sideways movement to a mildly bearish trend. Despite a recent downgrade from Sell to Hold by MarketsMOJO on 18 Feb 2026, the stock’s technical landscape reveals both bullish and bearish signals, warranting a nuanced analysis for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Gland Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-03-04 08:06:55

Gland Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more sideways trend as of early March 2026. Despite a recent downgrade in daily moving averages and a slight dip in share price, the company’s weekly and monthly technical indicators present a complex picture, reflecting mixed signals for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Gland Pharma Ltd Valuation Shift Signals Price Attractiveness Amid Sector Dynamics

2026-03-04 08:01:32

Gland Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle improvement in price attractiveness. Despite a recent day decline of 1.79%, the pharmaceutical company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more balanced valuation relative to its historical levels and peer group, signalling a potential recalibration for investors assessing the stock’s medium-term prospects.

Read full news article

Gland Pharma Ltd Opens with Significant Gap Down Amid Market Concerns

2026-03-02 13:34:22

Gland Pharma Ltd commenced trading today with a pronounced gap down, opening at a price 6.74% lower than its previous close, reflecting heightened market concerns and a continuation of recent downward momentum in the pharmaceutical sector.

Read full news article

Gland Pharma Ltd is Rated Hold by MarketsMOJO

2026-03-02 10:10:03

Gland Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article